TNF-α is a key downstream effector cytokine across diverse areas of PsA (39, 56), and TNF-α inhibitors have been widely used for the treatment of PsA (3, 38, 57), and they have shown efficacy in the prevention of PsA in patients with psoriasis (58). Here, TNF is linked to psoriasis.